nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—CACNA2D2—mammary gland—breast cancer	0.0116	0.103	CbGeAlD
Pregabalin—CACNA2D1—mammary gland—breast cancer	0.00833	0.0738	CbGeAlD
Pregabalin—SLC1A1—endometrium—breast cancer	0.00802	0.071	CbGeAlD
Pregabalin—SLC1A1—pituitary gland—breast cancer	0.00726	0.0643	CbGeAlD
Pregabalin—SLC1A1—adipose tissue—breast cancer	0.00723	0.064	CbGeAlD
Pregabalin—SLC1A1—female reproductive system—breast cancer	0.00665	0.0588	CbGeAlD
Pregabalin—CACNA1A—adrenal gland—breast cancer	0.00665	0.0588	CbGeAlD
Pregabalin—SLC1A1—adrenal gland—breast cancer	0.00649	0.0574	CbGeAlD
Pregabalin—SLC1A1—female gonad—breast cancer	0.00605	0.0535	CbGeAlD
Pregabalin—SLC1A1—endocrine gland—breast cancer	0.00562	0.0498	CbGeAlD
Pregabalin—CACNA2D2—pituitary gland—breast cancer	0.00524	0.0463	CbGeAlD
Pregabalin—CACNA2D2—adrenal gland—breast cancer	0.00468	0.0414	CbGeAlD
Pregabalin—CACNA2D2—endocrine gland—breast cancer	0.00406	0.0359	CbGeAlD
Pregabalin—SLC1A1—lymph node—breast cancer	0.00389	0.0344	CbGeAlD
Pregabalin—CACNA2D1—adipose tissue—breast cancer	0.00375	0.0332	CbGeAlD
Pregabalin—CACNA2D1—adrenal gland—breast cancer	0.00336	0.0298	CbGeAlD
Pregabalin—CACNA2D1—bone marrow—breast cancer	0.00325	0.0288	CbGeAlD
Pregabalin—CACNA2D1—female gonad—breast cancer	0.00314	0.0278	CbGeAlD
Pregabalin—CACNA2D1—endocrine gland—breast cancer	0.00292	0.0258	CbGeAlD
Pregabalin—CACNA2D2—lymph node—breast cancer	0.0028	0.0248	CbGeAlD
Pregabalin—CACNA2D1—lymph node—breast cancer	0.00202	0.0178	CbGeAlD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—COX11—breast cancer	0.00093	0.00771	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00093	0.00771	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—STK11—breast cancer	0.000876	0.00727	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—FASN—breast cancer	0.000857	0.00712	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.00085	0.00706	CbGpPWpGaD
Pregabalin—CACNA2D2—Regulation of insulin secretion—ITPR1—breast cancer	0.00085	0.00706	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—BCHE—breast cancer	0.000835	0.00693	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000834	0.00692	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000818	0.00679	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000818	0.00679	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—SLC2A1—breast cancer	0.000814	0.00676	CbGpPWpGaD
Pregabalin—CACNA1A—Integration of energy metabolism—ITPR1—breast cancer	0.000798	0.00662	CbGpPWpGaD
Pregabalin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—breast cancer	0.000741	0.00615	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—ACHE—breast cancer	0.000735	0.0061	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—STK11—breast cancer	0.000734	0.00609	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000704	0.00585	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—ACHE—breast cancer	0.000693	0.00575	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000669	0.00555	CbGpPWpGaD
Pregabalin—CACNA2D2—Integration of energy metabolism—ITPR1—breast cancer	0.000668	0.00555	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—COMT—breast cancer	0.000668	0.00554	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000646	0.00536	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000644	0.00535	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—BCHE—breast cancer	0.00064	0.00531	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—BCHE—breast cancer	0.000604	0.00501	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000599	0.00497	CbGpPWpGaD
Pregabalin—CACNA1A—Calcium Regulation in the Cardiac Cell—ITPR1—breast cancer	0.000598	0.00497	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—ACHE—breast cancer	0.000581	0.00482	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—ACHE—breast cancer	0.000531	0.00441	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—COMT—breast cancer	0.000512	0.00425	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000509	0.00423	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—BCHE—breast cancer	0.000506	0.0042	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—COMT—breast cancer	0.000483	0.00401	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—BCHE—breast cancer	0.000463	0.00384	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—ACHE—breast cancer	0.000445	0.00369	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—BRAF—breast cancer	0.000426	0.00354	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000424	0.00352	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000415	0.00345	CbGpPWpGaD
Pregabalin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—breast cancer	0.000413	0.00343	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—COMT—breast cancer	0.000404	0.00336	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—BCHE—breast cancer	0.000388	0.00322	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SYNJ2—breast cancer	0.00038	0.00315	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.00037	0.00307	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—COMT—breast cancer	0.00037	0.00307	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—MDM2—breast cancer	0.000357	0.00296	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000356	0.00296	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—RAF1—breast cancer	0.000356	0.00295	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NDUFS3—breast cancer	0.000353	0.00293	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.00034	0.00282	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CHST9—breast cancer	0.000332	0.00276	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000328	0.00272	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—BRAF—breast cancer	0.000327	0.00271	CbGpPWpGaD
Pregabalin—SLC1A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000319	0.00265	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SYNJ2—breast cancer	0.000318	0.00264	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—COX11—breast cancer	0.000315	0.00261	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—COMT—breast cancer	0.00031	0.00257	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—BRAF—breast cancer	0.000308	0.00256	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.0003	0.00249	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NDUFS3—breast cancer	0.000296	0.00246	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000293	0.00243	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CDA—breast cancer	0.000288	0.00239	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SHMT1—breast cancer	0.000288	0.00239	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CHST9—breast cancer	0.000278	0.00231	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLCO1B1—breast cancer	0.000277	0.0023	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC2A5—breast cancer	0.000277	0.0023	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—MDM2—breast cancer	0.000274	0.00227	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—RAF1—breast cancer	0.000273	0.00226	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.00027	0.00224	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—APRT—breast cancer	0.000268	0.00222	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—COX11—breast cancer	0.000264	0.00219	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000259	0.00215	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—BRAF—breast cancer	0.000258	0.00214	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—MDM2—breast cancer	0.000258	0.00214	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—RAF1—breast cancer	0.000257	0.00214	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ESRRA—breast cancer	0.000252	0.00209	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ANGPTL4—breast cancer	0.000252	0.00209	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CDA—breast cancer	0.000241	0.002	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SHMT1—breast cancer	0.000241	0.002	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HADHB—breast cancer	0.000239	0.00198	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GPI—breast cancer	0.000239	0.00198	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—BRAF—breast cancer	0.000236	0.00196	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC2A5—breast cancer	0.000232	0.00193	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLCO1B1—breast cancer	0.000232	0.00193	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALDH1A1—breast cancer	0.000228	0.00189	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALDH7A1—breast cancer	0.000228	0.00189	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—APRT—breast cancer	0.000224	0.00186	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—UMPS—breast cancer	0.000218	0.00181	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—FHL2—breast cancer	0.000218	0.00181	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NME1—breast cancer	0.000218	0.00181	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ADSL—breast cancer	0.000218	0.00181	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PHGDH—breast cancer	0.000218	0.00181	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—MDM2—breast cancer	0.000216	0.0018	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—RAF1—breast cancer	0.000216	0.00179	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HPSE—breast cancer	0.000214	0.00178	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—BRIP1—breast cancer	0.000214	0.00178	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—LDHB—breast cancer	0.000214	0.00178	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ANGPTL4—breast cancer	0.000211	0.00175	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ESRRA—breast cancer	0.000211	0.00175	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA3—breast cancer	0.000203	0.00168	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HMMR—breast cancer	0.000203	0.00168	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ABCC1—breast cancer	0.000203	0.00168	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GPI—breast cancer	0.0002	0.00166	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HADHB—breast cancer	0.0002	0.00166	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—BRAF—breast cancer	0.000198	0.00164	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—MDM2—breast cancer	0.000198	0.00164	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—RAF1—breast cancer	0.000197	0.00164	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PPARGC1B—breast cancer	0.000196	0.00163	CbGpPWpGaD
Pregabalin—SLC1A1—Transmission across Chemical Synapses—HRAS—breast cancer	0.000196	0.00163	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALDH7A1—breast cancer	0.000191	0.00158	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALDH1A1—breast cancer	0.000191	0.00158	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CA9—breast cancer	0.000186	0.00154	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA4—breast cancer	0.000186	0.00154	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—FHL2—breast cancer	0.000183	0.00152	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NME1—breast cancer	0.000183	0.00152	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—UMPS—breast cancer	0.000183	0.00152	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ADSL—breast cancer	0.000183	0.00152	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PHGDH—breast cancer	0.000183	0.00152	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA2—breast cancer	0.000181	0.0015	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GPX2—breast cancer	0.000181	0.0015	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HPSE—breast cancer	0.000179	0.00149	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—BRIP1—breast cancer	0.000179	0.00149	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—LDHB—breast cancer	0.000179	0.00149	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GPX4—breast cancer	0.000179	0.00148	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SULT1A1—breast cancer	0.000179	0.00148	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTA1—breast cancer	0.000174	0.00145	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—IDH1—breast cancer	0.000174	0.00145	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NAT2—breast cancer	0.000172	0.00143	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ABCC1—breast cancer	0.00017	0.00141	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA3—breast cancer	0.00017	0.00141	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HMMR—breast cancer	0.00017	0.00141	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—MDM2—breast cancer	0.000166	0.00138	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—RAF1—breast cancer	0.000165	0.00137	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PPARGC1B—breast cancer	0.000165	0.00137	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—ALB—breast cancer	0.000162	0.00135	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CA9—breast cancer	0.000155	0.00129	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA4—breast cancer	0.000155	0.00129	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA2—breast cancer	0.000151	0.00126	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GPX2—breast cancer	0.000151	0.00126	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—MED12—breast cancer	0.000151	0.00126	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—DPYD—breast cancer	0.000151	0.00126	CbGpPWpGaD
Pregabalin—SLC1A1—Neuronal System—HRAS—breast cancer	0.00015	0.00125	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GPX4—breast cancer	0.00015	0.00124	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SULT1A1—breast cancer	0.00015	0.00124	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALDOA—breast cancer	0.000149	0.00124	CbGpPWpGaD
Pregabalin—SLC1A1—Transmembrane transport of small molecules—RAF1—breast cancer	0.000147	0.00122	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—IDH1—breast cancer	0.000146	0.00121	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTA1—breast cancer	0.000146	0.00121	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NAT2—breast cancer	0.000145	0.0012	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NCOA3—breast cancer	0.000145	0.0012	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC2A2—breast cancer	0.000144	0.00119	CbGpPWpGaD
Pregabalin—CACNA1A—Transmission across Chemical Synapses—HRAS—breast cancer	0.000142	0.00118	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CPT1A—breast cancer	0.000141	0.00117	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—MTR—breast cancer	0.000141	0.00117	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ABCG2—breast cancer	0.000141	0.00117	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HPGDS—breast cancer	0.000138	0.00114	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HBA1—breast cancer	0.000137	0.00114	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTT1—breast cancer	0.000134	0.00111	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ACHE—breast cancer	0.000134	0.00111	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—MED12—breast cancer	0.000127	0.00105	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—DPYD—breast cancer	0.000127	0.00105	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP17A1—breast cancer	0.000127	0.00105	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ENO1—breast cancer	0.000125	0.00104	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTGS1—breast cancer	0.000125	0.00104	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALDOA—breast cancer	0.000125	0.00104	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP2D6—breast cancer	0.000123	0.00102	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NCOA3—breast cancer	0.000121	0.00101	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NCOA2—breast cancer	0.000121	0.001	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC2A2—breast cancer	0.00012	0.000998	CbGpPWpGaD
Pregabalin—CACNA2D2—Transmission across Chemical Synapses—HRAS—breast cancer	0.000119	0.000985	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—MTR—breast cancer	0.000118	0.000978	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ABCG2—breast cancer	0.000118	0.000978	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CPT1A—breast cancer	0.000118	0.000978	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—FASN—breast cancer	0.000117	0.000971	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—BCHE—breast cancer	0.000116	0.000967	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HPGDS—breast cancer	0.000116	0.000959	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC5A5—breast cancer	0.000115	0.000955	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HBA1—breast cancer	0.000115	0.000953	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTT1—breast cancer	0.000112	0.00093	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ACHE—breast cancer	0.000112	0.00093	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—SLC2A1—breast cancer	0.000111	0.000922	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NQO1—breast cancer	0.000111	0.000922	CbGpPWpGaD
Pregabalin—CACNA1A—Neuronal System—HRAS—breast cancer	0.000109	0.000901	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP3A4—breast cancer	0.000108	0.000899	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP1B1—breast cancer	0.000107	0.000884	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP17A1—breast cancer	0.000106	0.00088	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ENO1—breast cancer	0.000105	0.000872	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PTGS1—breast cancer	0.000105	0.000872	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HSP90AA1—breast cancer	0.000104	0.000867	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP2D6—breast cancer	0.000103	0.000855	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NCOA1—breast cancer	0.000102	0.000844	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NCOA2—breast cancer	0.000101	0.000839	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP19A1—breast cancer	0.0001	0.000831	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—STK11—breast cancer	0.0001	0.000831	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—FASN—breast cancer	9.8e-05	0.000814	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—BCHE—breast cancer	9.76e-05	0.00081	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC5A5—breast cancer	9.64e-05	0.0008	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NQO1—breast cancer	9.31e-05	0.000773	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—SLC2A1—breast cancer	9.31e-05	0.000773	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—COMT—breast cancer	9.31e-05	0.000773	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTP1—breast cancer	9.27e-05	0.000769	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—HMOX1—breast cancer	9.14e-05	0.000759	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ITPR1—breast cancer	9.12e-05	0.000757	CbGpPWpGaD
Pregabalin—CACNA2D2—Neuronal System—HRAS—breast cancer	9.1e-05	0.000755	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP3A4—breast cancer	9.08e-05	0.000754	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP1B1—breast cancer	8.93e-05	0.000741	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ABCB1—breast cancer	8.77e-05	0.000728	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HSP90AA1—breast cancer	8.76e-05	0.000727	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—TYMS—breast cancer	8.62e-05	0.000715	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NCOA1—breast cancer	8.52e-05	0.000707	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PLA2G4A—breast cancer	8.52e-05	0.000707	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NCOR1—breast cancer	8.52e-05	0.000707	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GSTM1—breast cancer	8.52e-05	0.000707	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP19A1—breast cancer	8.39e-05	0.000697	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—STK11—breast cancer	8.39e-05	0.000697	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—GPX1—breast cancer	8.16e-05	0.000677	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CYP1A1—breast cancer	8.07e-05	0.00067	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ERCC2—breast cancer	8.01e-05	0.000665	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—COMT—breast cancer	7.8e-05	0.000648	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTP1—breast cancer	7.77e-05	0.000645	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—HMOX1—breast cancer	7.66e-05	0.000636	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ITPR1—breast cancer	7.64e-05	0.000634	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—MTHFR—breast cancer	7.53e-05	0.000625	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ABCB1—breast cancer	7.35e-05	0.00061	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—TYMS—breast cancer	7.22e-05	0.000599	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PLA2G4A—breast cancer	7.14e-05	0.000592	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GSTM1—breast cancer	7.14e-05	0.000592	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NCOR1—breast cancer	7.14e-05	0.000592	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—CAV1—breast cancer	6.94e-05	0.000576	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—GPX1—breast cancer	6.84e-05	0.000567	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CYP1A1—breast cancer	6.77e-05	0.000562	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ERCC2—breast cancer	6.71e-05	0.000557	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CG—breast cancer	6.32e-05	0.000525	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—MTHFR—breast cancer	6.31e-05	0.000524	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—CAV1—breast cancer	5.82e-05	0.000483	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CD—breast cancer	5.56e-05	0.000461	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—ALB—breast cancer	5.49e-05	0.000456	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CG—breast cancer	5.3e-05	0.00044	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—NOS3—breast cancer	5.25e-05	0.000436	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PIK3CB—breast cancer	4.85e-05	0.000402	CbGpPWpGaD
Pregabalin—CACNA1A—Metabolism—PTGS2—breast cancer	4.8e-05	0.000399	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—PIK3CD—breast cancer	4.66e-05	0.000387	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—ALB—breast cancer	4.6e-05	0.000382	CbGpPWpGaD
Pregabalin—CACNA2D2—Metabolism—NOS3—breast cancer	4.4e-05	0.000365	CbGpPWpGaD
Pregabalin—Dysgeusia—Methotrexate—breast cancer	4.39e-05	5.73e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Docetaxel—breast cancer	4.38e-05	5.72e-05	CcSEcCtD
Pregabalin—Connective tissue disorder—Doxorubicin—breast cancer	4.38e-05	5.72e-05	CcSEcCtD
Pregabalin—Dyspnoea—Capecitabine—breast cancer	4.38e-05	5.72e-05	CcSEcCtD
Pregabalin—Fatigue—Docetaxel—breast cancer	4.38e-05	5.71e-05	CcSEcCtD
Pregabalin—Angiopathy—Epirubicin—breast cancer	4.37e-05	5.71e-05	CcSEcCtD
Pregabalin—Urethral disorder—Doxorubicin—breast cancer	4.37e-05	5.7e-05	CcSEcCtD
Pregabalin—Nausea—Mitoxantrone—breast cancer	4.36e-05	5.69e-05	CcSEcCtD
Pregabalin—Nausea—Irinotecan—breast cancer	4.36e-05	5.69e-05	CcSEcCtD
Pregabalin—Immune system disorder—Epirubicin—breast cancer	4.35e-05	5.68e-05	CcSEcCtD
Pregabalin—Mediastinal disorder—Epirubicin—breast cancer	4.35e-05	5.67e-05	CcSEcCtD
Pregabalin—Constipation—Docetaxel—breast cancer	4.34e-05	5.67e-05	CcSEcCtD
Pregabalin—Pain—Docetaxel—breast cancer	4.34e-05	5.67e-05	CcSEcCtD
Pregabalin—Back pain—Methotrexate—breast cancer	4.34e-05	5.66e-05	CcSEcCtD
Pregabalin—Chills—Epirubicin—breast cancer	4.33e-05	5.64e-05	CcSEcCtD
Pregabalin—Arrhythmia—Epirubicin—breast cancer	4.31e-05	5.62e-05	CcSEcCtD
Pregabalin—Visual impairment—Doxorubicin—breast cancer	4.3e-05	5.61e-05	CcSEcCtD
Pregabalin—Asthenia—Paclitaxel—breast cancer	4.3e-05	5.61e-05	CcSEcCtD
Pregabalin—Decreased appetite—Capecitabine—breast cancer	4.27e-05	5.58e-05	CcSEcCtD
Pregabalin—Alopecia—Epirubicin—breast cancer	4.26e-05	5.56e-05	CcSEcCtD
Pregabalin—Nausea—Gemcitabine—breast cancer	4.25e-05	5.55e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Capecitabine—breast cancer	4.24e-05	5.54e-05	CcSEcCtD
Pregabalin—Fatigue—Capecitabine—breast cancer	4.24e-05	5.53e-05	CcSEcCtD
Pregabalin—Pruritus—Paclitaxel—breast cancer	4.24e-05	5.53e-05	CcSEcCtD
Pregabalin—Vision blurred—Methotrexate—breast cancer	4.23e-05	5.51e-05	CcSEcCtD
Pregabalin—Mental disorder—Epirubicin—breast cancer	4.22e-05	5.51e-05	CcSEcCtD
Pregabalin—Erythema multiforme—Doxorubicin—breast cancer	4.22e-05	5.5e-05	CcSEcCtD
Pregabalin—Pain—Capecitabine—breast cancer	4.2e-05	5.49e-05	CcSEcCtD
Pregabalin—Constipation—Capecitabine—breast cancer	4.2e-05	5.49e-05	CcSEcCtD
Pregabalin—Malnutrition—Epirubicin—breast cancer	4.2e-05	5.48e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PTEN—breast cancer	4.19e-05	0.000348	CbGpPWpGaD
Pregabalin—Feeling abnormal—Docetaxel—breast cancer	4.18e-05	5.46e-05	CcSEcCtD
Pregabalin—Nausea—Fluorouracil—breast cancer	4.18e-05	5.45e-05	CcSEcCtD
Pregabalin—Eye disorder—Doxorubicin—breast cancer	4.17e-05	5.44e-05	CcSEcCtD
Pregabalin—Ill-defined disorder—Methotrexate—breast cancer	4.16e-05	5.43e-05	CcSEcCtD
Pregabalin—Tinnitus—Doxorubicin—breast cancer	4.16e-05	5.43e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Docetaxel—breast cancer	4.15e-05	5.42e-05	CcSEcCtD
Pregabalin—Anaemia—Methotrexate—breast cancer	4.15e-05	5.41e-05	CcSEcCtD
Pregabalin—Flushing—Doxorubicin—breast cancer	4.14e-05	5.4e-05	CcSEcCtD
Pregabalin—Cardiac disorder—Doxorubicin—breast cancer	4.14e-05	5.4e-05	CcSEcCtD
Pregabalin—Flatulence—Epirubicin—breast cancer	4.14e-05	5.4e-05	CcSEcCtD
Pregabalin—Tension—Epirubicin—breast cancer	4.12e-05	5.37e-05	CcSEcCtD
Pregabalin—Dysgeusia—Epirubicin—breast cancer	4.11e-05	5.36e-05	CcSEcCtD
Pregabalin—Diarrhoea—Paclitaxel—breast cancer	4.1e-05	5.35e-05	CcSEcCtD
Pregabalin—Nervousness—Epirubicin—breast cancer	4.08e-05	5.32e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PIK3CB—breast cancer	4.06e-05	0.000337	CbGpPWpGaD
Pregabalin—Back pain—Epirubicin—breast cancer	4.06e-05	5.3e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Capecitabine—breast cancer	4.05e-05	5.29e-05	CcSEcCtD
Pregabalin—Angiopathy—Doxorubicin—breast cancer	4.05e-05	5.28e-05	CcSEcCtD
Pregabalin—Malaise—Methotrexate—breast cancer	4.04e-05	5.28e-05	CcSEcCtD
Pregabalin—Muscle spasms—Epirubicin—breast cancer	4.04e-05	5.26e-05	CcSEcCtD
Pregabalin—Immune system disorder—Doxorubicin—breast cancer	4.03e-05	5.26e-05	CcSEcCtD
Pregabalin—Vertigo—Methotrexate—breast cancer	4.03e-05	5.26e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PTGS2—breast cancer	4.02e-05	0.000334	CbGpPWpGaD
Pregabalin—Gastrointestinal pain—Capecitabine—breast cancer	4.02e-05	5.25e-05	CcSEcCtD
Pregabalin—Mediastinal disorder—Doxorubicin—breast cancer	4.02e-05	5.25e-05	CcSEcCtD
Pregabalin—Body temperature increased—Docetaxel—breast cancer	4.01e-05	5.24e-05	CcSEcCtD
Pregabalin—Abdominal pain—Docetaxel—breast cancer	4.01e-05	5.24e-05	CcSEcCtD
Pregabalin—Leukopenia—Methotrexate—breast cancer	4.01e-05	5.24e-05	CcSEcCtD
Pregabalin—Chills—Doxorubicin—breast cancer	4e-05	5.22e-05	CcSEcCtD
Pregabalin—Arrhythmia—Doxorubicin—breast cancer	3.99e-05	5.2e-05	CcSEcCtD
Pregabalin—Dizziness—Paclitaxel—breast cancer	3.96e-05	5.17e-05	CcSEcCtD
Pregabalin—Vision blurred—Epirubicin—breast cancer	3.96e-05	5.16e-05	CcSEcCtD
Pregabalin—Alopecia—Doxorubicin—breast cancer	3.94e-05	5.14e-05	CcSEcCtD
Pregabalin—Cough—Methotrexate—breast cancer	3.91e-05	5.11e-05	CcSEcCtD
Pregabalin—Mental disorder—Doxorubicin—breast cancer	3.91e-05	5.1e-05	CcSEcCtD
Pregabalin—Urticaria—Capecitabine—breast cancer	3.91e-05	5.1e-05	CcSEcCtD
Pregabalin—Ill-defined disorder—Epirubicin—breast cancer	3.89e-05	5.08e-05	CcSEcCtD
Pregabalin—Abdominal pain—Capecitabine—breast cancer	3.89e-05	5.07e-05	CcSEcCtD
Pregabalin—Body temperature increased—Capecitabine—breast cancer	3.89e-05	5.07e-05	CcSEcCtD
Pregabalin—Convulsion—Methotrexate—breast cancer	3.89e-05	5.07e-05	CcSEcCtD
Pregabalin—Malnutrition—Doxorubicin—breast cancer	3.88e-05	5.07e-05	CcSEcCtD
Pregabalin—Anaemia—Epirubicin—breast cancer	3.88e-05	5.06e-05	CcSEcCtD
Pregabalin—Agitation—Epirubicin—breast cancer	3.86e-05	5.03e-05	CcSEcCtD
Pregabalin—Flatulence—Doxorubicin—breast cancer	3.83e-05	4.99e-05	CcSEcCtD
Pregabalin—Arthralgia—Methotrexate—breast cancer	3.82e-05	4.98e-05	CcSEcCtD
Pregabalin—Myalgia—Methotrexate—breast cancer	3.82e-05	4.98e-05	CcSEcCtD
Pregabalin—Chest pain—Methotrexate—breast cancer	3.82e-05	4.98e-05	CcSEcCtD
Pregabalin—Tension—Doxorubicin—breast cancer	3.81e-05	4.97e-05	CcSEcCtD
Pregabalin—Vomiting—Paclitaxel—breast cancer	3.81e-05	4.97e-05	CcSEcCtD
Pregabalin—Dysgeusia—Doxorubicin—breast cancer	3.8e-05	4.96e-05	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.79e-05	4.95e-05	CcSEcCtD
Pregabalin—Malaise—Epirubicin—breast cancer	3.78e-05	4.94e-05	CcSEcCtD
Pregabalin—Rash—Paclitaxel—breast cancer	3.78e-05	4.93e-05	CcSEcCtD
Pregabalin—Dermatitis—Paclitaxel—breast cancer	3.77e-05	4.92e-05	CcSEcCtD
Pregabalin—Discomfort—Methotrexate—breast cancer	3.77e-05	4.92e-05	CcSEcCtD
Pregabalin—Nervousness—Doxorubicin—breast cancer	3.77e-05	4.92e-05	CcSEcCtD
Pregabalin—Vertigo—Epirubicin—breast cancer	3.77e-05	4.92e-05	CcSEcCtD
Pregabalin—Syncope—Epirubicin—breast cancer	3.76e-05	4.91e-05	CcSEcCtD
Pregabalin—Leukopenia—Epirubicin—breast cancer	3.76e-05	4.9e-05	CcSEcCtD
Pregabalin—Back pain—Doxorubicin—breast cancer	3.76e-05	4.9e-05	CcSEcCtD
Pregabalin—Headache—Paclitaxel—breast cancer	3.75e-05	4.9e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Docetaxel—breast cancer	3.74e-05	4.88e-05	CcSEcCtD
Pregabalin—Muscle spasms—Doxorubicin—breast cancer	3.73e-05	4.87e-05	CcSEcCtD
Pregabalin—Palpitations—Epirubicin—breast cancer	3.71e-05	4.84e-05	CcSEcCtD
Pregabalin—Confusional state—Methotrexate—breast cancer	3.69e-05	4.81e-05	CcSEcCtD
Pregabalin—Loss of consciousness—Epirubicin—breast cancer	3.69e-05	4.81e-05	CcSEcCtD
Pregabalin—Cough—Epirubicin—breast cancer	3.66e-05	4.78e-05	CcSEcCtD
Pregabalin—Anaphylactic shock—Methotrexate—breast cancer	3.66e-05	4.78e-05	CcSEcCtD
Pregabalin—Vision blurred—Doxorubicin—breast cancer	3.66e-05	4.77e-05	CcSEcCtD
Pregabalin—Asthenia—Docetaxel—breast cancer	3.64e-05	4.75e-05	CcSEcCtD
Pregabalin—Convulsion—Epirubicin—breast cancer	3.64e-05	4.74e-05	CcSEcCtD
Pregabalin—Infection—Methotrexate—breast cancer	3.64e-05	4.74e-05	CcSEcCtD
Pregabalin—Hypertension—Epirubicin—breast cancer	3.62e-05	4.73e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Capecitabine—breast cancer	3.62e-05	4.73e-05	CcSEcCtD
Pregabalin—Ill-defined disorder—Doxorubicin—breast cancer	3.6e-05	4.7e-05	CcSEcCtD
Pregabalin—Pruritus—Docetaxel—breast cancer	3.59e-05	4.69e-05	CcSEcCtD
Pregabalin—Nervous system disorder—Methotrexate—breast cancer	3.59e-05	4.68e-05	CcSEcCtD
Pregabalin—Anaemia—Doxorubicin—breast cancer	3.59e-05	4.68e-05	CcSEcCtD
Pregabalin—Thrombocytopenia—Methotrexate—breast cancer	3.58e-05	4.68e-05	CcSEcCtD
Pregabalin—Myalgia—Epirubicin—breast cancer	3.57e-05	4.66e-05	CcSEcCtD
Pregabalin—Arthralgia—Epirubicin—breast cancer	3.57e-05	4.66e-05	CcSEcCtD
Pregabalin—Chest pain—Epirubicin—breast cancer	3.57e-05	4.66e-05	CcSEcCtD
Pregabalin—Agitation—Doxorubicin—breast cancer	3.57e-05	4.66e-05	CcSEcCtD
Pregabalin—Anxiety—Epirubicin—breast cancer	3.56e-05	4.65e-05	CcSEcCtD
Pregabalin—Nausea—Paclitaxel—breast cancer	3.56e-05	4.64e-05	CcSEcCtD
Pregabalin—Skin disorder—Methotrexate—breast cancer	3.56e-05	4.64e-05	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.55e-05	4.63e-05	CcSEcCtD
Pregabalin—Hyperhidrosis—Methotrexate—breast cancer	3.54e-05	4.62e-05	CcSEcCtD
Pregabalin—Discomfort—Epirubicin—breast cancer	3.53e-05	4.61e-05	CcSEcCtD
Pregabalin—Asthenia—Capecitabine—breast cancer	3.53e-05	4.6e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PTEN—breast cancer	3.51e-05	0.000291	CbGpPWpGaD
Pregabalin—Malaise—Doxorubicin—breast cancer	3.5e-05	4.57e-05	CcSEcCtD
Pregabalin—Dry mouth—Epirubicin—breast cancer	3.49e-05	4.56e-05	CcSEcCtD
Pregabalin—Vertigo—Doxorubicin—breast cancer	3.49e-05	4.55e-05	CcSEcCtD
Pregabalin—Anorexia—Methotrexate—breast cancer	3.49e-05	4.55e-05	CcSEcCtD
Pregabalin—Syncope—Doxorubicin—breast cancer	3.48e-05	4.54e-05	CcSEcCtD
Pregabalin—Pruritus—Capecitabine—breast cancer	3.48e-05	4.54e-05	CcSEcCtD
Pregabalin—Leukopenia—Doxorubicin—breast cancer	3.48e-05	4.53e-05	CcSEcCtD
Pregabalin—Diarrhoea—Docetaxel—breast cancer	3.47e-05	4.53e-05	CcSEcCtD
Pregabalin—Confusional state—Epirubicin—breast cancer	3.45e-05	4.51e-05	CcSEcCtD
Pregabalin—Palpitations—Doxorubicin—breast cancer	3.43e-05	4.48e-05	CcSEcCtD
Pregabalin—Oedema—Epirubicin—breast cancer	3.43e-05	4.47e-05	CcSEcCtD
Pregabalin—Anaphylactic shock—Epirubicin—breast cancer	3.43e-05	4.47e-05	CcSEcCtD
Pregabalin—Hypotension—Methotrexate—breast cancer	3.42e-05	4.46e-05	CcSEcCtD
Pregabalin—Loss of consciousness—Doxorubicin—breast cancer	3.41e-05	4.45e-05	CcSEcCtD
Pregabalin—Infection—Epirubicin—breast cancer	3.4e-05	4.44e-05	CcSEcCtD
Pregabalin—Cough—Doxorubicin—breast cancer	3.39e-05	4.42e-05	CcSEcCtD
Pregabalin—Shock—Epirubicin—breast cancer	3.37e-05	4.4e-05	CcSEcCtD
Pregabalin—Convulsion—Doxorubicin—breast cancer	3.36e-05	4.39e-05	CcSEcCtD
Pregabalin—Diarrhoea—Capecitabine—breast cancer	3.36e-05	4.39e-05	CcSEcCtD
Pregabalin—Nervous system disorder—Epirubicin—breast cancer	3.36e-05	4.38e-05	CcSEcCtD
Pregabalin—Dizziness—Docetaxel—breast cancer	3.36e-05	4.38e-05	CcSEcCtD
Pregabalin—Thrombocytopenia—Epirubicin—breast cancer	3.35e-05	4.38e-05	CcSEcCtD
Pregabalin—Hypertension—Doxorubicin—breast cancer	3.35e-05	4.37e-05	CcSEcCtD
Pregabalin—Tachycardia—Epirubicin—breast cancer	3.34e-05	4.36e-05	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Methotrexate—breast cancer	3.33e-05	4.35e-05	CcSEcCtD
Pregabalin—Skin disorder—Epirubicin—breast cancer	3.33e-05	4.34e-05	CcSEcCtD
Pregabalin—Hyperhidrosis—Epirubicin—breast cancer	3.31e-05	4.32e-05	CcSEcCtD
Pregabalin—Insomnia—Methotrexate—breast cancer	3.31e-05	4.32e-05	CcSEcCtD
Pregabalin—Arthralgia—Doxorubicin—breast cancer	3.31e-05	4.31e-05	CcSEcCtD
Pregabalin—Myalgia—Doxorubicin—breast cancer	3.31e-05	4.31e-05	CcSEcCtD
Pregabalin—Chest pain—Doxorubicin—breast cancer	3.31e-05	4.31e-05	CcSEcCtD
Pregabalin—Anxiety—Doxorubicin—breast cancer	3.29e-05	4.3e-05	CcSEcCtD
Pregabalin—Paraesthesia—Methotrexate—breast cancer	3.29e-05	4.29e-05	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.28e-05	4.28e-05	CcSEcCtD
Pregabalin—Discomfort—Doxorubicin—breast cancer	3.27e-05	4.26e-05	CcSEcCtD
Pregabalin—Anorexia—Epirubicin—breast cancer	3.27e-05	4.26e-05	CcSEcCtD
Pregabalin—Dyspnoea—Methotrexate—breast cancer	3.26e-05	4.26e-05	CcSEcCtD
Pregabalin—Somnolence—Methotrexate—breast cancer	3.25e-05	4.25e-05	CcSEcCtD
Pregabalin—Dizziness—Capecitabine—breast cancer	3.25e-05	4.24e-05	CcSEcCtD
Pregabalin—Dry mouth—Doxorubicin—breast cancer	3.23e-05	4.22e-05	CcSEcCtD
Pregabalin—Vomiting—Docetaxel—breast cancer	3.23e-05	4.21e-05	CcSEcCtD
Pregabalin—Rash—Docetaxel—breast cancer	3.2e-05	4.18e-05	CcSEcCtD
Pregabalin—Hypotension—Epirubicin—breast cancer	3.2e-05	4.18e-05	CcSEcCtD
Pregabalin—Dermatitis—Docetaxel—breast cancer	3.2e-05	4.17e-05	CcSEcCtD
Pregabalin—Confusional state—Doxorubicin—breast cancer	3.2e-05	4.17e-05	CcSEcCtD
Pregabalin—Decreased appetite—Methotrexate—breast cancer	3.18e-05	4.15e-05	CcSEcCtD
Pregabalin—Headache—Docetaxel—breast cancer	3.18e-05	4.15e-05	CcSEcCtD
Pregabalin—Oedema—Doxorubicin—breast cancer	3.17e-05	4.13e-05	CcSEcCtD
Pregabalin—Anaphylactic shock—Doxorubicin—breast cancer	3.17e-05	4.13e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Methotrexate—breast cancer	3.16e-05	4.12e-05	CcSEcCtD
Pregabalin—Fatigue—Methotrexate—breast cancer	3.16e-05	4.12e-05	CcSEcCtD
Pregabalin—Infection—Doxorubicin—breast cancer	3.15e-05	4.11e-05	CcSEcCtD
Pregabalin—Pain—Methotrexate—breast cancer	3.13e-05	4.08e-05	CcSEcCtD
Pregabalin—Vomiting—Capecitabine—breast cancer	3.13e-05	4.08e-05	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Epirubicin—breast cancer	3.12e-05	4.07e-05	CcSEcCtD
Pregabalin—Shock—Doxorubicin—breast cancer	3.12e-05	4.07e-05	CcSEcCtD
Pregabalin—Nervous system disorder—Doxorubicin—breast cancer	3.11e-05	4.05e-05	CcSEcCtD
Pregabalin—Thrombocytopenia—Doxorubicin—breast cancer	3.1e-05	4.05e-05	CcSEcCtD
Pregabalin—Rash—Capecitabine—breast cancer	3.1e-05	4.04e-05	CcSEcCtD
Pregabalin—Insomnia—Epirubicin—breast cancer	3.1e-05	4.04e-05	CcSEcCtD
Pregabalin—Dermatitis—Capecitabine—breast cancer	3.1e-05	4.04e-05	CcSEcCtD
Pregabalin—Tachycardia—Doxorubicin—breast cancer	3.09e-05	4.04e-05	CcSEcCtD
Pregabalin—Headache—Capecitabine—breast cancer	3.08e-05	4.02e-05	CcSEcCtD
Pregabalin—Skin disorder—Doxorubicin—breast cancer	3.08e-05	4.02e-05	CcSEcCtD
Pregabalin—Paraesthesia—Epirubicin—breast cancer	3.08e-05	4.01e-05	CcSEcCtD
Pregabalin—Hyperhidrosis—Doxorubicin—breast cancer	3.06e-05	4e-05	CcSEcCtD
Pregabalin—Dyspnoea—Epirubicin—breast cancer	3.05e-05	3.98e-05	CcSEcCtD
Pregabalin—Somnolence—Epirubicin—breast cancer	3.05e-05	3.97e-05	CcSEcCtD
Pregabalin—Anorexia—Doxorubicin—breast cancer	3.02e-05	3.94e-05	CcSEcCtD
Pregabalin—Nausea—Docetaxel—breast cancer	3.02e-05	3.94e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Methotrexate—breast cancer	3.02e-05	3.93e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Methotrexate—breast cancer	2.99e-05	3.9e-05	CcSEcCtD
Pregabalin—Decreased appetite—Epirubicin—breast cancer	2.98e-05	3.88e-05	CcSEcCtD
Pregabalin—Hypotension—Doxorubicin—breast cancer	2.96e-05	3.86e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Epirubicin—breast cancer	2.96e-05	3.86e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—PIK3CA—breast cancer	2.95e-05	0.000245	CbGpPWpGaD
Pregabalin—Fatigue—Epirubicin—breast cancer	2.95e-05	3.85e-05	CcSEcCtD
Pregabalin—Constipation—Epirubicin—breast cancer	2.93e-05	3.82e-05	CcSEcCtD
Pregabalin—Pain—Epirubicin—breast cancer	2.93e-05	3.82e-05	CcSEcCtD
Pregabalin—Nausea—Capecitabine—breast cancer	2.92e-05	3.81e-05	CcSEcCtD
Pregabalin—Urticaria—Methotrexate—breast cancer	2.91e-05	3.79e-05	CcSEcCtD
Pregabalin—Abdominal pain—Methotrexate—breast cancer	2.89e-05	3.77e-05	CcSEcCtD
Pregabalin—Body temperature increased—Methotrexate—breast cancer	2.89e-05	3.77e-05	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.89e-05	3.77e-05	CcSEcCtD
Pregabalin—Insomnia—Doxorubicin—breast cancer	2.87e-05	3.74e-05	CcSEcCtD
Pregabalin—Paraesthesia—Doxorubicin—breast cancer	2.85e-05	3.71e-05	CcSEcCtD
Pregabalin—Dyspnoea—Doxorubicin—breast cancer	2.83e-05	3.69e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Epirubicin—breast cancer	2.82e-05	3.68e-05	CcSEcCtD
Pregabalin—Somnolence—Doxorubicin—breast cancer	2.82e-05	3.68e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Epirubicin—breast cancer	2.8e-05	3.65e-05	CcSEcCtD
Pregabalin—Decreased appetite—Doxorubicin—breast cancer	2.76e-05	3.59e-05	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Doxorubicin—breast cancer	2.74e-05	3.57e-05	CcSEcCtD
Pregabalin—Fatigue—Doxorubicin—breast cancer	2.73e-05	3.56e-05	CcSEcCtD
Pregabalin—Urticaria—Epirubicin—breast cancer	2.72e-05	3.55e-05	CcSEcCtD
Pregabalin—Pain—Doxorubicin—breast cancer	2.71e-05	3.54e-05	CcSEcCtD
Pregabalin—Constipation—Doxorubicin—breast cancer	2.71e-05	3.54e-05	CcSEcCtD
Pregabalin—Abdominal pain—Epirubicin—breast cancer	2.71e-05	3.53e-05	CcSEcCtD
Pregabalin—Body temperature increased—Epirubicin—breast cancer	2.71e-05	3.53e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Methotrexate—breast cancer	2.7e-05	3.52e-05	CcSEcCtD
Pregabalin—Asthenia—Methotrexate—breast cancer	2.63e-05	3.43e-05	CcSEcCtD
Pregabalin—Feeling abnormal—Doxorubicin—breast cancer	2.61e-05	3.41e-05	CcSEcCtD
Pregabalin—Gastrointestinal pain—Doxorubicin—breast cancer	2.59e-05	3.38e-05	CcSEcCtD
Pregabalin—Pruritus—Methotrexate—breast cancer	2.59e-05	3.38e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Epirubicin—breast cancer	2.52e-05	3.29e-05	CcSEcCtD
Pregabalin—Urticaria—Doxorubicin—breast cancer	2.52e-05	3.28e-05	CcSEcCtD
Pregabalin—Body temperature increased—Doxorubicin—breast cancer	2.51e-05	3.27e-05	CcSEcCtD
Pregabalin—Abdominal pain—Doxorubicin—breast cancer	2.51e-05	3.27e-05	CcSEcCtD
Pregabalin—Diarrhoea—Methotrexate—breast cancer	2.5e-05	3.27e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—PIK3CA—breast cancer	2.48e-05	0.000205	CbGpPWpGaD
Pregabalin—Asthenia—Epirubicin—breast cancer	2.46e-05	3.21e-05	CcSEcCtD
Pregabalin—Pruritus—Epirubicin—breast cancer	2.42e-05	3.16e-05	CcSEcCtD
Pregabalin—Dizziness—Methotrexate—breast cancer	2.42e-05	3.16e-05	CcSEcCtD
Pregabalin—CACNA1A—Metabolism—AKT1—breast cancer	2.41e-05	0.0002	CbGpPWpGaD
Pregabalin—Diarrhoea—Epirubicin—breast cancer	2.34e-05	3.06e-05	CcSEcCtD
Pregabalin—Hypersensitivity—Doxorubicin—breast cancer	2.34e-05	3.05e-05	CcSEcCtD
Pregabalin—Vomiting—Methotrexate—breast cancer	2.33e-05	3.04e-05	CcSEcCtD
Pregabalin—Rash—Methotrexate—breast cancer	2.31e-05	3.01e-05	CcSEcCtD
Pregabalin—Dermatitis—Methotrexate—breast cancer	2.31e-05	3.01e-05	CcSEcCtD
Pregabalin—Headache—Methotrexate—breast cancer	2.29e-05	2.99e-05	CcSEcCtD
Pregabalin—Asthenia—Doxorubicin—breast cancer	2.27e-05	2.97e-05	CcSEcCtD
Pregabalin—Dizziness—Epirubicin—breast cancer	2.27e-05	2.96e-05	CcSEcCtD
Pregabalin—Pruritus—Doxorubicin—breast cancer	2.24e-05	2.93e-05	CcSEcCtD
Pregabalin—Vomiting—Epirubicin—breast cancer	2.18e-05	2.84e-05	CcSEcCtD
Pregabalin—Nausea—Methotrexate—breast cancer	2.17e-05	2.84e-05	CcSEcCtD
Pregabalin—Diarrhoea—Doxorubicin—breast cancer	2.17e-05	2.83e-05	CcSEcCtD
Pregabalin—Rash—Epirubicin—breast cancer	2.16e-05	2.82e-05	CcSEcCtD
Pregabalin—Dermatitis—Epirubicin—breast cancer	2.16e-05	2.81e-05	CcSEcCtD
Pregabalin—Headache—Epirubicin—breast cancer	2.15e-05	2.8e-05	CcSEcCtD
Pregabalin—Dizziness—Doxorubicin—breast cancer	2.1e-05	2.73e-05	CcSEcCtD
Pregabalin—Nausea—Epirubicin—breast cancer	2.03e-05	2.65e-05	CcSEcCtD
Pregabalin—CACNA2D2—Metabolism—AKT1—breast cancer	2.02e-05	0.000168	CbGpPWpGaD
Pregabalin—Vomiting—Doxorubicin—breast cancer	2.02e-05	2.63e-05	CcSEcCtD
Pregabalin—Rash—Doxorubicin—breast cancer	2e-05	2.61e-05	CcSEcCtD
Pregabalin—Dermatitis—Doxorubicin—breast cancer	2e-05	2.6e-05	CcSEcCtD
Pregabalin—Headache—Doxorubicin—breast cancer	1.99e-05	2.59e-05	CcSEcCtD
Pregabalin—Nausea—Doxorubicin—breast cancer	1.88e-05	2.46e-05	CcSEcCtD
